Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives

The present invention relates to a therapeutic agent for osteoporosis which comprises an active ingredient of quercetin derivatives. The quercetin derivatives of the invention can be practically applied for the treatment and prevention of osteoporosis, since they effectively inhibit osteoclast proli...

Full description

Saved in:
Bibliographic Details
Main Authors KIM CHUNG-SOOK. HA HYE-HYUNG, SONG KYE-YONG
Format Patent
LanguageEnglish
Published 23.03.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a therapeutic agent for osteoporosis which comprises an active ingredient of quercetin derivatives. The quercetin derivatives of the invention can be practically applied for the treatment and prevention of osteoporosis, since they effectively inhibit osteoclast proliferation and stimulate osteoblast proliferation more than conventional therapeutic agents for osteoporosis, and increase trabecular bone area highly without changing hormone level in body and untoward effects on hematopoietic function and immune system.
Bibliography:Application Number: CN20018001856